Summary Testicular germ cell tumours (TGCTs) of adolescents and adults morphologically mimic different stages of embryogenesis. Established cell lines of these cancers are used as informative models to study early development. We found that, in contrast to normal development, TGCTs show a consistent biallelic expression of imprinted genes, including H19, irrespective of histology. Methylation of particular cytosine residues of H19 correlates with inhibition of expression, which has not been studied in TGCTs thus far. We investigated the methylation status of two CpG sites within the 3' region of H19 (exon 5: positions 3321 and 3324) both in normal tissues as well as in TGCTs. To obtain quantitative data of these specific sites, the ligation-mediated polymerase chain reaction technique, instead of Southern blot analysis, was applied. The results were compared with the allelic status and the total level of expression of this gene. Additionally, the undifferentiated cells and differentiated derivatives of the TGCT-derived cell line NT2-D1 were analysed. While peripheral blood showed no H19 expression and complete methylation, a heterogeneous but consistent pattern of methylation and level of expression was found in the other normal tissues, without a correlation between the two. The separate histological entities of TGCTs resembled the pattern of their nonmalignant tissues. While the CpG sites remained completely methylated in NT2-D1, H19 expression was induced upon differentiation. These data indicate that methylation of the CpG sites within exon 5 of H19 is tissue dependent, without regulating allelic status and/or total level of expression. Of special note is the finding that, also regarding methylation of these particular sites of H19, TGCTs mimic their non-malignant counterparts, in spite of their consistent biallelic expression.
Expression of a, thus far, limited number of mouse and human genes is found to be influenced by their parental origin (Kato et al, 1996; Looijenga et al, 1996 for review). The growing list of reports about (possible) associations between aberrant expression of these so-called imprinted genes and non-neoplastic or neoplastic pathological conditions stresses the importance of this topic in medical research. In particular, biallelic expression, i.e. loss of imprinting (LOI), of one or more imprinted genes has been found in a number of cancers (Feinberg, 1993; Rainier et al, 1993 Rainier et al, , 1995 Steenman et al, 1994; Zhan et al, 1994 Zhan et al, , 1995 Kondo et al, 1995; Li et al, 1995; Taniguchi et al, 1995; Douc-Rasy et al, 1996 ; Hibi et al, 1996; Riou et al, 1996; Uyeno et al, 1996 . In contrast to the finding of biallelic expression of H19, one of the imprinted genes expressed predominantly during early development (Brunkow and Tilghman, 1991; Poirier et al, 1991; Lustig et al, 1994; Leighton et al, 1995) , in only a certain percentage of the different neoplasms studied, we reported on the consistent biallelic expression of H19 in human testicular gern cell tumours of adolescents and adults (TGCTs) (Van Gurp et al, 1994; , which has recently been confirmed by others (Mishina et al, 1996) . In spite of the exceptional histological diversity of this particular cancer (Mostofi et al, 1987; Oosterhuis and Looijenga, 1993) , both the seminomas (SEs), showing characteristics of early (primordial) germ cells and the non-seminomatous TGCTs (NSs) in which the undifferentiated stem cells [embryonal carcinomas (ECs) ] can differentiate into embryonal [teratoma (TE)] and extraembryonal elements [yolk sac tumour (YS) and choriocarcinoma (CH)] expressed both the paternal and maternal allele in an approximately equal amount. In addition, we found evidence that the common precursor of TGCTs, known as carcinoma in situ (Skakkebek et al, 1987) , also shows biallelic expression of H19 , analogous to mouse primordial germ cells (Szabo and Mann, 1995) . Our hypothesis is that the biallelic expression of H19, and possibly all imprinted genes (Rachmilewitz et al, 1996) , in TGCTs is due to retention of an intrinsic feature of their cell of origin, a transformed primordial germ cell.
One of the likely mechanisms responsible for the allele-specific expression of imprinted genes under physiological conditions is methylation of cytosine residues, an epigenetic mechanism generally involved in the regulation of gene expression in vertebrates (Eden and Cedar, 1994 for review) . While DNA methylation is in principle stable and inherited in somatic daughter cells, multiple studies have indicated that methylation of DNA can be differentiation and/or maturation dependent (Monk, 1990; Luebbert et al, 1991; Shemer et al, 1991) . For example, extensive demethylation has been reported during early mouse embryogenesis (Howlett and Reik, 1991; Kafri et al, 1992; Razin and Shemer, 1995) , in which the primordial germ cells are found to be highly demethylated (Kafri et al, 1992) . Earlier publications on methylation of several non-imprinted genes in SEs and NSs indicate that SEs are, like primordial germ cells, highly demethylated, while the NSs show more methylation, like somatic tissues (Peltomaki, 1991) . Several studies have been published dealing with the methylation status of mouse and human imprinted genes (Bartolomei et al, 1993; Ferguson-Smith et al, 1993; Stoger et al, 1993; Zhang et al, 1993; Feil et al, 1994; Labosky et al, 1994; Moulton et al, 1994; Reik and Allen, 1994; Steenman et al, 1994; Szabo and Mann, 1994; Jinno et al, 1995; Sasaki et al, 1995; Taniguchi et al, 1995; Tremblay et al, 1995; Douc-Rasy et al, 1996) . Most of the results were obtained using Southern blot analysis, although this method does not result in quantitative data, and interpretation of regions containing many and/or closely apposed recognition sites of the methylation-sensitive restriction endonuclease is troublesome. These limitations can be solved using the recently developed ligation-mediated polymerase chain reaction (LM-PCR) (Pfeifer et al, 1989; McGrew and Rosenthal, 1993) . This technique allows a quantitative methylation analysis of individual cytosine residues within a particular stretch of DNA.
We used LM-PCR to study the similarities and differences in methylation status of two specific CpG sites within the 3' region of HJ9 ( (Brannan et al, 1990 ) including the polymorphic RsaI site (position 3238) was cloned into SacIISmaI-digested PGEM-3Z plasmid (Promega). To generate the antisense probe, in vitro transcription of 1 jg of plasmid DNA in the presence of [a-32P] CTP was performed using Sp6 RNA polymerase after linearization of the plasmid with EcoRI. As control, a sense probe was generated similarly after linearization of the plasmid with HindIlI and transcription using T7 RNA polymerase. As reference for the amount of RNA used for the analysis, a y-actin antisense probe was constructed as follows. A 129-bp Hinfi-HindIl fragment (Enoch et al, 1986) was subcloned into the SmaI/HindIII site of the PGEM4Z plasmid (Promega) micrograms of RNA was used for the analysis using the Ribonuclease Protection Assay Kit RPA II (Ambion), according to the manufacturer's description. After hybridization, the samples were treated with RNAase (1:100) for 1 h at 37°C. The samples were loaded onto a 6% polyacrylamide/8 M urea gel and electrophoresed for 3 h at 60 W, after which the gel was vacuum dried. Subsequently, exposure was performed to CEA RP films (medical radiograph screen film blue sensitive, Cea Corps) for various lengths of time at -80°C. Interpretation of the autoradiographs was established using a videodensitometer (2600, Biorad) with appropriate software applications as recommended by the supplier. Within each lane, the relative intensity of the H19 signal was determined compared with that of the y-actin signal, after compensating for background signal. The intensity of the smallest actin band (four protected fragments were found by RNAase protection analysis) was used as reference. The intensity is approximately one-fifth of the total actin signal present. Therefore, the relative level of H19 expression compared with the actin signal is a fivefold overestimation of the absolute level.
Reverse transcription polymerase chain reaction (RT-PCR)
Five micrograms of total RNA, isolated as described above, was reverse transcribed. cDNA was generated at 37°C for 2 h in a total Amplifications were performed using 2 gl of the RT reaction in a total volume of 50 gl containing 1 x Taq DNA polymerase buffer with 1.5 mm magnesium chloride, 100 pmol of each primer, 250 mm each dNTP and 1 U of Taq DNA polymerase (Promega). A primer set, referred to as HN9 and HN1O, spanning intron 3 and 4 (DNA fragment 949 bp, cDNA fragment 788 bp) was used. Primer positions are: forward primer HN9 (5'-bp ACTTCCTCCAGGGAGTCGGCA-3') and reverse primer HNIO (5'-TGATGATGAGTCCAGGGCTCCT-3'), derived from positions 3453-3474 of the published HJ9 sequence (which was renumbered by us, starting at 1 at the beginning of the published sequence; Brannan et al, 1990) . After an initial denaturation of 4 min at 94°C, every amplification cycle consisted (between 30 and 35 cycles) of 1 min at 94°C, 2 min at 66°C and 2 min at 72°C. Hypoxanthine phosphoribosyl transferase (HPRT) primers were used (243 and 244; Gibbs et al, 1989) to validate the integrity of the cDNA. PCR products were visualized on 2.5-3% [50% regular and 50% NuSieve GTG (FMC)] agarose gels stained with ethidium bromide.
The samples were studied to provide information on the polymorphic RsaI restriction site in exon S (Zhang and Tycko, 1992) , amplified with primerset HN9 and HN1O. High-molecular-weight DNA was isolated using proteinase K-sodium dodecyl sulphate treatment followed by phenol-chloroform extraction and ethanol precipitation (Maniatis et al, 1982) . Again, tissue sections were used to verify histological composition. Amplification products (5-10 gl) were digested to completion with 40 U of RsaI endonuclease (Pharmacia). Heterozygous samples showed an uncleaved band of 949 bp and cleaved bands of 714 bp and 235 bp. The matched RNAs were judged as biallelic when the cDNA amplification products after digestion showed the uncleaved 788-bp band as well as the cleaved 553-bp and 235-bp bands. Completion of digestion was tested by always including a sample homozygous for the allele with the RsaI site. In addition, at least three independent digests were performed for each sample. High-molecular-weight DNA was isolated using standard procedures from the histologically checked samples as described above. Six micrograms of DNA was digested with the restriction endonuclease BglI. After ethanol precipitation, the pellet was resolved in 20 p1 of water. Completeness of digestion was checked by performing a PCR using primers HN9 and HN1O (see above). The samples were only used for further analysis when no amplification products could be identified after agarose gel electrophoresis and ethidium bromide staining. The proper samples were split into four identical fractions. These were digested overnight at 37°C using the restriction endonucleases HpaII, HhaI and MspI and no restriction endonuclease as control. For the LM-PCR, all samples and solutions were chilled on ice before use. The digested DNA samples were subjected to the procedure described previously (Pfeifer et al, 1989; McGrew and Rosenthal, 1993) , with some modifications. To each aliquot (1.5 jig of DNA), 25 jil of 'first-strand mixture' was added (48 mm sodium chloride, 12 mm Tris HCI pH 8.9, 6 mm magnesium sulphate, 0.012% gelatin) and 0.3 pmol of the gene specific primer HP-I (5'-GGCTCCTGCTGAAGCCCT-3'), 240 polymerase were added. The labelling cycle consisted of 3.5 min at 950C, 2 min at 620C and 10 min at 720C, 1 min at 950C, 2 min at 620C and 10 min at 720C. The samples were extracted using phenol-chloroform and subsequently ethanol precipitated using 0.2 M NaAc. After resuspension of the pellet in 10 p1 of loading buffer, 2.5 p1 was heated for 5 min at 950C, chilled on ice and loaded on a 6% 0.4-mm polyacrylamide sequencing gel. Exposure was done overnight at -800C, and the autoradiographs were analysed quantitatively as described above.
Growth of the cell line NT2-D1
The TGCT-derived cell line NT2-D1 was grown two-dimensionally in tissue culture-treated flasks (Costar) under standard conditions, i.e. 37°C, 5% carbon dioxide in air-humidified atmosphere in Dulbecco's modified Eagle medium (DMEM)/HF12 with 10% heat-inactivated fetal calf serum (FCS) (BRL-GIBCO). Subsequently, the cells were exposed to 105 M all-trans retinoic acid (RA, Sigma) for various lengths of time. RNA from the different time points was isolated and studied for H19 expression as described above.
RESULTS
RNAase protection analysis and reverse transcription polymerase chain reaction To obtain a general impression of the total level ofH19 expression in the samples included in this study, we applied RNAase protection British Journal of Cancer (1997) 76(6), 725-733 Relatively high expression was found in placenta, skeletal muscle and adrenal gland (in decreasing order), in agreement with published data (Rachmilewitz et al, 1992; Douc-Rasy et al, 1993; Goshen et al, 1993; Walsh et al, 1995) . The other normal tissues (kidney, heart, liver, uterus, thymus, lung and testis) showed a low level or no expression (spleen, epididymis and peripheral blood). A consistent low level of expression was found in SEs (n = 24, mean 0.16, standard deviation 0.074), while the NSs showed a variable level of expression (n = 13, mean 1.25, standard deviation 1.12), being significantly different (P < 0.005, Student's t-test, unpaired analysis). Within the group of NSs, lower expression was detected in the samples without extraembryonal elements (indicated as N1 in Figure  IA) , while a higher expression was found in tumours containing a YS and/or a CH component (indicated as N2 in Figure 1A .
Thus far, in a series of more than 60 primary TGCTs, including the samples studied here, no deletions including H19 could be identified (unpublished observations), in spite of a high frequency of loss of heterozygosity of Ilpl5.5 (Lothe et al, 1993; Looijenga et al, 1994; Lothe et al, 1995; Peng et al, 1995) . In contrast, a recent study reported the presence of deletions including H19 in about 25% of TGCTs (Mishina et al, 1996) . As reported previously (Van Gurp et al, 1994; Verkerk et al, 1996) , TGCTs show a consistent biallelic expression of H19, irrespective of histology and total level of expression, as also found by others more recently (Mishina et al, 1996) . In contrast, normal tissues, including full-term placenta, normal testis and epididymis samples show monoallelic expression (not shown, Verkerk et al, 1996 Douc-Rasy et al, 1996; Hibi et al, 1996; Mishina et al, 1996) . No expression of this gene could be found with RT-PCR in peripheral blood, concordant with RNAase protection analysis (see above and reported previously by . Differentiation of the cell line NT2-D1 upon retinoic acid exposure resulted in a strong induction of H19 expression, illustrated by RT-PCR ( Figure 1B Figure 2A . The primers used, as well as the technique itself, are schematically illustrated in Figure 2B . To verify complete digestion of the DNA samples to be tested, Bgll and BglIMspI controls were included in every experiment (see Materials and methods). When these samples resulted solely in detection of the 134-bp and 77-bp fragments, respectively, the HpaII-and HhaI-digested samples were interpreted. Only the methylation status of the most 3'-located CpG sites (within one HpaII and one HhaI site) will be discussed hereafter, unless indicated otherwise.
A variable level of methylation was detected for the cytosine residues within the HpaII (CCGG) and HhaI recognition sites (GCGC) in the normal tissues, of which the total percentage (not differentiated to one of the cytosine residues for the HpaII site) is shown in Table 1 . Representative examples of the LM-PCR analysis are shown in Figure 3A . A high level of methylation of both sites was found in thyroid gland, peripheral blood and spleen. Because this HpaII site of H19 was found to be completely methylated in peripheral blood, indicating that both the paternal and maternal allele are methylated, the level of methylation of the more upstream-located CpG site (position 3308, see Figure 2A ) could also be analysed. This site was again found to be completely methylated, just as the CpG site at position 3287. Most other tissues showed a methylation level between 50% and 70% for the most 3'-located HpaII site and the HhaI-site, with a slightly lower level in skeletal and heart muscle as well as in uterus. For both sites, a low level of methylation was detected in full-term placenta, indicating at least that not all maternal or paternal alleles present are methylated. Possible contamination of blood cells in these samples, explaining the remaining level of methylation, could not be excluded, although MspI digestion resulted only in the 77-bp fragment, indicating complete digestion (not shown). Also a relatively low level of methylation was detected in samples predominantly consisting of germ cells (normal testis parenchyma and epididymis), indicating that the majority of the alleles present are unmethylated. This was found to be significantly lower compared with the samples of adult somatic tissues (P < 0.005 for HhaI and P < 0.0005 for HpaII, Student's t-test, unpaired analysis).
Tissue-dependent methylation of Hi9 -exon 5 731
The results on methylation of these HpaII and HhaI sites of the tumours are also indicated in Table 1, of which representative examples are shown in Figure 3B . For (Brunkow and Tilghman, 1991; Poirier et al, 1991 , Lustig et al, 1994 Leighton et al, 1995) , is imprinted, i.e. shows uniparental expression in most tissues (Bartolomei et al, 1991; Zhang and Tycko, 1992; Zhang et al, 1993; Sasaki et al, 1995; Svensson et al, 1995) . In contrast, TGCTs, which are overall rare, but common malignancies in Caucasian men aged between 15 and 45 years (Feuer, 1995; M0ller et al, 1995; Bergstrom et al, 1996) , show consistent biallelic expression of this gene, irrespective of the histological composition of the cancer (this manuscript and Van Gurp et al, 1994; Verkerk et al, 1996) . This finding is of importance because all TGCTs originate from a common precursor, referred to as carcinoma in situ (Skakkebaek et al, 1987) , which is assumed to be the malignant counterpart of a primordial germ cell that is initiated during intrauterine development (J0rgensen et al, 1995) . Interestingly, it has been found that mouse primordial germ cells show biallelic expression of imprinted genes, including HJ9 (Szabo and Mann, 1995) and, in accordance with this finding, we detected specifically biallelic expression of H19 in testicular parenchyma containing carcinoma in situ .
These data suggest that TGCTs show biallelic expression of H19, and possibly of other imprinted genes (Rachmilewitz et al, 1996) , as a result of retention of 'primordial germ cell-like' characteristics. The results on total level of expression of H19, obtained by RNAase protection analysis and mRNA in situ hybridization (this paper and Verkerk et al, 1996) , also show strong similarities with the expression pattern found during early development for review). The mechanistic basis for lack of establishment of monoallelic expression in TGCTs showing loss of the primordial germ cell characteristics, i.e. the NSs, as found during normal embryogenesis is unclear as yet, but aberrant methylation could be involved.
The mouse and human inactive (paternal) allele is found to be hypermethylated compared with the active (maternal) allele (Bartolomei et al, 1993; Ferguson-Smith et al, 1993; Zhang et al, 1993) . Indeed, that methylation has a role in, at least, the final establishment of this uniparental pattern of expression has recently been demonstrated by the finding of expression of both parental alleles of H19 in DNA methylase-deficient mice (Li et al, 1993) . Moreover, hypermethylation of both the paternal and maternal H19 alleles has been found in cancers of different origin showing down-regulation of expression of the normally active allele (Zhang et al, 1993; Moulton et al, 1994; Steenman et al, 1994; Taniguchi et al, 1995) . Because Southern blot analysis was applied in these studies, it was most often not possible to identify the methylation status of the individual cytosine residues. This is, however, possible using the technique of LM-PCR. We used this method to investigate quantitatively the relationship between allelic status and total level of H19 expression and methylation of two CpG sites within exon 5 of this gene (position 3321 and 3324) in normal tissues as well as in TGCTs. These sites were chosen, because they have been found to be differentially methylated between the maternal and paternal allele in normal tissues (Zhang et al, 1993; Moulton et al, 1994; Jinno et al, 1995) and to be hypermethylated in Wilms' tumours showing LOI and down-regulation of total H19 expression (Moulton et al, 1994; Steenman et al, 1994; Taniguchi et al, 1995) . In addition, the reported shift from biallelic towards monoallelic expression of H19 during maturation of human placenta is accompanied by a progressive methylation of the 3'-region, which encompasses these specific sites, of the allele to be silenced (Jinno et al, 1995) . Therefore, a disturbed methylation pattern of H19 in TGCTs, which is in one way or another related to biallelic expression, could be demonstrated by analysis of these particular sites.
A heterogeneous, but consistent, pattern of methylation in the normal and malignant tissues was found. In spite of the correlation between hypermethylation and lack of H19 expression, as found in peripheral blood, the other normal and malignant tissues, as well as the TGCT-derived cell line, showed no such correlation. The fact that full-term placenta showed retention of monoallelic expression and a low level of methylation (less than 15%) indicates that absence of differential methylation of these sites does not lead to biallelic expression per se, as found by overall demethylation in DNA methylase-deficient mice (Li et al, 1993) . In addition, the high level of methylation in spleen and thyroid gland, both showing monoallelic expression, also indicates that hypermethylation does not always result in inhibition of expression. This is supported by the results found in the cell line NT2-Dl. The low level of expression and low methylation in SEs also indicates that demethylation of these sites does not result in upregulation of expression, supported by the findings in the NSs. These percentages also show that methylation of these particular sites is not restricted to all alleles derived from one parent, indicating that they are not directly involved in the mechanism of genomic imprinting. In summary, we conclude that regulation of HJ9 expression (allele specific and total) can not be attributed to the differential methylation pattern of the CpG sites analysed in this study and that the level of methylation is determined by tissuespecific factors. In agreement with these data, it was recently reported that the 5'-region of both the mouse and human HI9 gene seems to harbour the critical region showing parental originspecific methylation, being involved in recognition of the parental alleles as well as the specific inhibition of expression of the paternal allele (Tremblay et al, 1995; Jinno et al, 1996) . Currently, the methylation status of this region is studied in the series reported here.
The discrepancy between the data reported by Jinno et al, (1995) , showing progressive hypermethylation of the 3'-region of H19 during development of human placenta and the low methylation status found by us is most probably due to the different methods used. In the first study, Southern blot analysis and subsequent hybridization with a region-specific probe was applied, showing up to 70% methylation. The CpG sites at positions 3321 and 3324, which we studied using LM-PCR, are mapped at the most 3' end, located on the 0.4-kb fragment of the allele with the recognition site for RsaI; this region allows no interpretation regarding methylation status in the survey performed on developing placenta. Moreover, it was recently shown, using an allelespecific mRNA in situ hybridization approach, that the shift from biallelic to monoallelic expression of H19 during placental development, as found by Jinno et al (1995) , is due to cell type-specific activation of the paternal allele (Adam et al, 1996) . Therefore, the methylation data in this particular tissue need reinterpretation.
The tissue-dependent pattern of methylation and H19 expression in the normal tissues, as reported here, seems to be retained in the TGCTs: hypomethylation and a low level of expression in SEs (as in samples with a large proportion of germ cells) and more methylation and an expression level dependent on the histological composition in NSs (as in the other normal tissues); this is in spite of the consistent biallelic expression of H19 in the tumours (Van Gurp et al, 1994; Verkerk et al, 1996) . The lower level of methylation found in NSs with a YS and/or CH component is of particular interest because of the reported hypomethylation of this gene in mouse extraembryonal tissues (Sasaki et al, 1995) . Interestingly, the hypomethylation of the samples containing a high proportion of cells belonging to the germ cell lineage implies that hypermethylation of the 3' region of H19 detected in both mouse and human sperm (Bartolomei et al, 1993; Zhang et al, 1993 ) is a relatively late event in the maturation of male germ cells.
In conclusion, despite the lack of correlation between methylation of two CpG sites within exon 5 of H19 and expression pattern in normal human tissues and TGCTs, our data support the model that TGCTs originate from a primordial germ cell and that these tumours mimic early development not only morphologically but also on their molecular level. This demonstrates the putative value of TGCTs as a model to study mechanisms involved in embryogenesis, including genomic imprinting.
